DK0421707T3 - Forbedringer i behandlingen af ufrugtbarhed - Google Patents
Forbedringer i behandlingen af ufrugtbarhedInfo
- Publication number
- DK0421707T3 DK0421707T3 DK90310729.0T DK90310729T DK0421707T3 DK 0421707 T3 DK0421707 T3 DK 0421707T3 DK 90310729 T DK90310729 T DK 90310729T DK 0421707 T3 DK0421707 T3 DK 0421707T3
- Authority
- DK
- Denmark
- Prior art keywords
- clonidine
- detecting whether
- gonadotropin
- blood level
- patient
- Prior art date
Links
- 208000000509 infertility Diseases 0.000 title 1
- 230000036512 infertility Effects 0.000 title 1
- 231100000535 infertility Toxicity 0.000 title 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 abstract 2
- 102000006771 Gonadotropins Human genes 0.000 abstract 2
- 108010086677 Gonadotropins Proteins 0.000 abstract 2
- 230000036765 blood level Effects 0.000 abstract 2
- 229960002896 clonidine Drugs 0.000 abstract 2
- 239000002622 gonadotropin Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- ZNIFSRGNXRYGHF-UHFFFAOYSA-N Clonidine hydrochloride Chemical compound Cl.ClC1=CC=CC(Cl)=C1NC1=NCCN1 ZNIFSRGNXRYGHF-UHFFFAOYSA-N 0.000 abstract 1
- 102100022831 Somatoliberin Human genes 0.000 abstract 1
- 101710142969 Somatoliberin Proteins 0.000 abstract 1
- 229960002925 clonidine hydrochloride Drugs 0.000 abstract 1
- 208000021267 infertility disease Diseases 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/61—Growth hormones [GH] (Somatotropin)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Vehicle Body Suspensions (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898922137A GB8922137D0 (en) | 1989-10-02 | 1989-10-02 | Improvements in the management of infertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0421707T3 true DK0421707T3 (da) | 1995-11-06 |
Family
ID=10663910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90310729.0T DK0421707T3 (da) | 1989-10-02 | 1990-10-01 | Forbedringer i behandlingen af ufrugtbarhed |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5175111A (da) |
| EP (1) | EP0421707B1 (da) |
| JP (1) | JP3087904B2 (da) |
| AT (1) | ATE127927T1 (da) |
| AU (1) | AU642909B2 (da) |
| CA (1) | CA2026639C (da) |
| DE (1) | DE69022344T2 (da) |
| DK (1) | DK0421707T3 (da) |
| ES (1) | ES2077032T3 (da) |
| GB (1) | GB8922137D0 (da) |
| GR (1) | GR3018087T3 (da) |
| IL (1) | IL95865A (da) |
| ZA (1) | ZA907865B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109813897A (zh) * | 2017-11-18 | 2019-05-28 | 镇江亿特生物科技发展有限公司 | 盐酸可乐定快速时间分辨荧光免疫层析定量检测试纸条 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633260A (da) * | 1962-02-05 | |||
| NL7707691A (nl) * | 1976-07-16 | 1978-01-18 | Hoechst Ag | Werkwijze voor het bereiden van nieuwe cyclopen- taanderivaten. |
| DE2834248A1 (de) * | 1978-08-04 | 1980-02-28 | Hoechst Ag | Neue prostaglandinderivate in der delta 2-pgf tief 2 und delta 2-pge tief 2 -reihe |
| IT1191611B (it) * | 1985-05-15 | 1988-03-23 | Eugenio E Muller | Formalazioni farmaceutiche per stimolare la liberazione di ormone somatotropo |
| US5091170A (en) * | 1987-03-17 | 1992-02-25 | Daniel Navot | Fertility prediction by use of clomiphene challenge test |
-
1989
- 1989-10-02 GB GB898922137A patent/GB8922137D0/en active Pending
-
1990
- 1990-10-01 ES ES90310729T patent/ES2077032T3/es not_active Expired - Lifetime
- 1990-10-01 CA CA002026639A patent/CA2026639C/en not_active Expired - Lifetime
- 1990-10-01 DE DE69022344T patent/DE69022344T2/de not_active Expired - Fee Related
- 1990-10-01 IL IL9586590A patent/IL95865A/en not_active IP Right Cessation
- 1990-10-01 US US07/592,441 patent/US5175111A/en not_active Expired - Lifetime
- 1990-10-01 EP EP90310729A patent/EP0421707B1/en not_active Expired - Lifetime
- 1990-10-01 AT AT90310729T patent/ATE127927T1/de not_active IP Right Cessation
- 1990-10-01 DK DK90310729.0T patent/DK0421707T3/da active
- 1990-10-02 AU AU63663/90A patent/AU642909B2/en not_active Ceased
- 1990-10-02 JP JP02264909A patent/JP3087904B2/ja not_active Expired - Fee Related
- 1990-10-02 ZA ZA907865A patent/ZA907865B/xx unknown
-
1995
- 1995-11-15 GR GR950403205T patent/GR3018087T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69022344D1 (de) | 1995-10-19 |
| JP3087904B2 (ja) | 2000-09-18 |
| IL95865A (en) | 1996-01-19 |
| AU6366390A (en) | 1991-04-11 |
| EP0421707B1 (en) | 1995-09-13 |
| US5175111A (en) | 1992-12-29 |
| ES2077032T3 (es) | 1995-11-16 |
| JPH03218467A (ja) | 1991-09-26 |
| ATE127927T1 (de) | 1995-09-15 |
| ZA907865B (en) | 1991-10-30 |
| GR3018087T3 (en) | 1996-02-29 |
| CA2026639C (en) | 2002-11-26 |
| EP0421707A3 (en) | 1992-07-15 |
| EP0421707A2 (en) | 1991-04-10 |
| GB8922137D0 (en) | 1989-11-15 |
| CA2026639A1 (en) | 1991-04-03 |
| IL95865A0 (en) | 1991-07-18 |
| DE69022344T2 (de) | 1996-03-07 |
| AU642909B2 (en) | 1993-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK77090A (da) | Immunmodulerende azaspiraner | |
| NO924209D0 (no) | Doseringsform for tilfoersel av et antiparkinsonmiddel | |
| IL92269A0 (en) | Pharmaceutical composition for treatment of autoimmune diseases | |
| PT87542A (pt) | Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease | |
| IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| EP1019072A4 (en) | ASSISTANCE PROCESS FOR DIFFERENTIAL DIAGNOSIS AND TREATMENT OF AUTISM SYNDROME | |
| CY1111088T1 (el) | Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση | |
| NO305932B1 (no) | Farmasoeytisk akseptabel L-DOPA-etylesterbase, et farmasoeytisk preparat innneholdende base, en fremgangsmåte for fremstilling av preparatet samt L-DOPA-etylesteren | |
| US4438138A (en) | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| GR1000419B (el) | Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. | |
| JPS6468320A (en) | Remedy for psychotic disease or like and therapeutical solution | |
| AU642909B2 (en) | Improvements in the management of infertility | |
| OA09027A (fr) | Procédé d'inhibition. d'un virus | |
| RU95111696A (ru) | Способ обезболивания офтальмологических операций | |
| SE8804640L (sv) | Laekemedel omfattande cyklolinopeptide a | |
| Contreras et al. | Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics. | |
| NO961180L (no) | Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom | |
| RU94023600A (ru) | Способ лечения гемохроматоза | |
| Bruguerolle et al. | Fever‐induced changes in theophylline pharmacokinetics in rats | |
| EP0309077A3 (en) | Antidiarrhoeal therapeutic agent | |
| SE8903117D0 (sv) | Laekemedel omfattande antamanid | |
| RU98107787A (ru) | Способ обезболивания офтальмологических операций |